The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Nausea From Mounjaro and Wegovy: What's the Difference?
Nausea is one of the most commonly reported side effects of both Mounjaro (tirzepatide) and Wegovy (semaglutide) in UK clinical trials. However, the frequency and severity can differ between the two medications due to their different mechanisms of action. Understanding how these prescription weight loss injections compare can help you and your GP or prescriber make an informed decision about which might be more suitable for you. This guide compares the nausea data from clinical trials and explains the science behind why each medication affects people differently.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Clinical Trial Data: Nausea Rates and Mechanism Differences
SURMOUNT trial data (Mounjaro): Nausea was reported by approximately 25–33% of participants on the maximum 15 mg dose. The SURMOUNT-1 trial showed nausea was most common in the first weeks of treatment and often decreased over time as the body adjusted.
STEP trial data (Wegovy): Nausea was reported by approximately 25–31% of participants on the maximum 2.4 mg dose, with similar patterns of improvement after the first few weeks.
Why the mechanism matters: Mounjaro is a dual GIP and GLP-1 receptor agonist, whereas Wegovy activates GLP-1 only. The dual action in Mounjaro may produce slightly different gastrointestinal effects, though individual responses vary considerably. Both work by slowing gastric emptying and reducing appetite signals.
- Nausea typically peaks during dose titration phases
- Nausea often improves after 4–8 weeks as the body adapts
- Staying hydrated and eating smaller, frequent meals can help manage symptoms
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Individual Response and Prescriber Suitability Assessment
Neither Mounjaro nor Wegovy is "better" for preventing nausea — individual responses vary significantly. Some people experience mild nausea that resolves quickly, whilst others find it more troublesome. Your prescriber will assess your personal health history, other medications, and any previous experience with GLP-1 medications when deciding which is more suitable for you.
Both medications require a prescription and clinical assessment from a UK-licensed healthcare professional. If nausea becomes severe or persistent with either medication, contact your prescriber — they may adjust your dose, slow your titration schedule, or recommend supportive measures. Use our free GLP-1 weight loss calculator to estimate potential outcomes, but remember that tolerability and side effects are individual factors that only your prescriber can evaluate properly.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is nausea more common with Mounjaro or Wegovy?
Clinical trials show similar nausea rates (approximately 25–33% on maximum doses). Individual experience varies greatly. Some people tolerate one better than the other. Your prescriber will assess which is more suitable based on your personal health profile and any previous medication sensitivities.
How long does nausea last when taking Mounjaro?
Nausea often peaks during the first 1–2 weeks of a new dose and typically improves within 4–8 weeks as your body adjusts. Some people experience mild nausea throughout treatment, whilst others find it resolves completely. Staying hydrated and eating small, frequent meals can help.
Can I switch from Mounjaro to Wegovy if I get nausea?
Switching is possible but requires your prescriber's guidance. Never stop or switch medications without consulting your GP or licensed prescriber. A slower dose titration schedule with either medication may help reduce nausea severity. Your prescriber can also recommend anti-nausea strategies.
Does the Mounjaro KwikPen cause nausea differently than other injection devices?
The KwikPen delivery method does not cause nausea — the nausea comes from the tirzepatide medication itself, not the device. All Mounjaro KwikPen doses deliver the same medication, so nausea risk is related to dose and individual tolerance, not the pen format.
What should I do if nausea is severe on Mounjaro or Wegovy?
Contact your prescriber immediately. Severe or persistent nausea may indicate you need a slower titration schedule, a lower maintenance dose, or a different approach. Never adjust your dose without guidance. Your GP can also discuss anti-nausea medications or other supportive measures suited to your situation.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.